↓ Skip to main content

PLOS

Potential Excess Mortality in BRCA1/2 Mutation Carriers beyond Breast, Ovarian, Prostate, and Pancreatic Cancers, and Melanoma

Overview of attention for article published in PLOS ONE, March 2009
Altmetric Badge

Mentioned by

blogs
1 blog
policy
2 policy sources

Citations

dimensions_citation
54 Dimensions

Readers on

mendeley
64 Mendeley
Title
Potential Excess Mortality in BRCA1/2 Mutation Carriers beyond Breast, Ovarian, Prostate, and Pancreatic Cancers, and Melanoma
Published in
PLOS ONE, March 2009
DOI 10.1371/journal.pone.0004812
Pubmed ID
Authors

Phuong L. Mai, Nilanjan Chatterjee, Patricia Hartge, Margaret Tucker, Lawrence Brody, Jeffery P. Struewing, Sholom Wacholder

Abstract

Although the increase in risk of developing breast, ovarian, and prostate cancer in BRCA1 and BRCA2 mutation carriers has been studied extensively, its impact on mortality is not well quantified. Further, possible effect of BRCA mutations on non-cancer mortality risk has not been examined.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 64 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Denmark 1 2%
Unknown 63 98%

Demographic breakdown

Readers by professional status Count As %
Researcher 16 25%
Student > Ph. D. Student 10 16%
Professor > Associate Professor 7 11%
Student > Master 5 8%
Lecturer 3 5%
Other 9 14%
Unknown 14 22%
Readers by discipline Count As %
Medicine and Dentistry 33 52%
Agricultural and Biological Sciences 8 13%
Biochemistry, Genetics and Molecular Biology 2 3%
Immunology and Microbiology 2 3%
Computer Science 1 2%
Other 6 9%
Unknown 12 19%